Immunization with Pre-Erythrocytic Antigen CelTOS from Plasmodium falciparum Elicits Cross-Species Protection against Heterologous Challenge with Plasmodium berghei

Elke S Bergmann-Leitner, Ryan M. Mease, Patricia De La Vega et al. · 2010

Read Immunization with Pre-Erythrocytic Antigen CelTOS from Plasmodium falciparum Elicits Cross-Species Protection against Heterologous Challenge with Plasmodium berghei by Elke S Bergmann-Leitner, Ryan M. Mease, Patricia De La Vega et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0012294.txt.

Description

Elke Bergmann-Leitner, Ryan Mease, Patricia De La Vega, and co-authors tested a malaria vaccine antigen in PLOS ONE in 2010. CelTOS is a protein malaria parasites use to cross through host cells, both in the mosquito and in the mammal they infect, and infection cannot succeed without it. Because the protein barely changes across malaria species, it raised a rare hope: one vaccine part protecting against several species at once.

Immunizing with CelTOS from the deadliest human malaria species protected animals against challenge with a different, mouse malaria species. Cross-species protection is the exception in malaria vaccinology, where most candidates guard only their own strain. A conserved weak point like this is exactly what a broadly useful vaccine needs.

Catalog record

CREATORElke S Bergmann-Leitner, Ryan M. Mease, Patricia De La Vega et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
LICENSECreative Commons CC0 License
RIGHTSCC0
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0012294

Browse the full library · About the Tower of Babel